Oxford Medical Products has revealed positive topline results from the first randomised controlled trial (RCT) of Sirona, its innovative, non-invasive and non-pharmaceutical weight loss technology.
A clinical trial has shown some positive findings for a new Alzheimer’s drug called Lecanemab.
More from us
Did you know with an ad-lite subscription to Worksop Guardian, you get 70% fewer ads while viewing the news that matters to you.
.jpg?trim=0,504,0,504&crop=&quality=70&width=129)
.jpg?trim=469,0,469,0&crop=&quality=70&width=129)
